Tumor-associated lymphangiogenesis promotes Treg accumulation, but dampens CD8+ effector T-cell infiltration in tumors, suggesting that tumoral LECs support an immunosuppressive microenvironment by impacting Tregs [69]. Here, CD8A is linked to neoplasm.